BEGIN:VCALENDAR
PRODID:Vermont Department of Health
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0400
END:STANDARD
END:VTIMEZONE
VERSION:2.0
BEGIN:VEVENT
UID:c1795712-36aa-4013-a524-2701c2a65b0c
SUMMARY:Mirtazapine for Methamphetamine Use Disorder
DTSTAMP:20261119T234900Z
DTSTART;TZID=America/New_York:20260512T120000
DTEND;TZID=America/New_York:20260512T130000
DESCRIPTION:Addiction Journal Club - Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical TrialAddiction Journal Club (AJC) is a monthly session where we meet to review an evidence-based, open-access article and discuss its implications for substance use disorder (SUD) practice. This includes new research and landmark studies relevant to SUD practice. AJC is distinct from other BMC Grayken Center for Addiction TTA events; it is designed to be less didactic and more of an interactive review of emerging data and trends related to caring for persons who use substances. It is also a great opportunity to network with addiction colleagues and share experiences about clinical practices.This month, we will be joined by Steven Shoptaw, PhD, one of the co-authors of the article, to review and discuss "Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical Trial" by McKetin R, Shoptaw S, Saunders L, et al. Click here to read the open-access article.Learn more and registerFor trai
LOCATION:Virtual
END:VEVENT
END:VCALENDAR